TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/11/24 17:46 | 9/9/24 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | FL | O | CFO | P.m | 150 | 2.80 | 0 | 53 | 153 | 88 | D | ||||||||||||||
1/31/24 18:28 | 1/29/24 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | FL | O | CFO | P.m | 126 | 3.85 | 0 | 33 | 999% | 35 | D | ||||||||||||||
10/21/19 16:23 | 10/21/19 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | D | P | 22 | 23.00 | 0 | 1 | 78 | 2 | D | |||||||||||||||
1/2/19 18:44 | 12/28/18 | AZRX | Azurrx Biopharma, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | DO | CFO | P | 26 | 1.31 | 0 | 20 | 47 | 63 | D | ||||||||||||||
12/17/15 09:37 | 12/15/15 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | D | P | 9 | 2.99 | 0 | 3 | 150 | 5 | D | |||||||||||||||
12/16/15 16:23 | 12/14/15 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Shenouda Maged | NY | D | P | 6 | 2.89 | 0 | 2 | New | 2 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |